迈瑞医疗冲击港股IPO，医疗器械ETF（562600）已连续10日获得资金净流入

Group 1 - The A-share market opened higher but declined, with the medical sector showing volatility. The medical device ETF (562600) fell by 0.54% but has seen net inflows for 10 consecutive trading days, with stocks like Jimin Health, Yirui Technology, and Hualan Biological leading the gains [1] - Mindray Medical, the largest component stock, submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange on November 10, with Huatai International and JPMorgan as joint sponsors [1] - The Chinese pharmaceutical industry has completed the transition of growth drivers, with medical devices and supply chains gaining a strong position globally. The demand and payment sides are continuously driving new growth, supported by the aging population and stable growth in medical insurance revenue [1] Group 2 - The long-term positive trend in the medical device sector remains unchanged, with the medical device ETF (562600) providing a convenient way to invest in this area. The ETF tracks the CSI All-Share Medical Device Index, which includes 100 representative companies in medical devices, services, and information technology [2] - Investors can also consider the 华夏中证全指医疗器械ETF发起式联接A (021250) and 华夏中证全指医疗器械ETF发起式联接C (021251) for easier access to the medical device sector [2]